Syncope or Seizures: What Have We Learned from Electrocardiographic Monitoring?

  • L. Bergfeldt
Conference paper


Syncope is a symptom defined as “a transient, self-limited loss of consciousness, usually leading to falling” [1]. The onset of syncope is relatively rapid, and the subsequent recovery is spontaneous, complete and usually prompt. The underlying mechanism is a transient global cerebral hypoperfusion. Seizure is, according to the same document, synonymous with an epileptic fit, and “...whatever its immediate or remote cause, an epileptic attack is the manifestation of a paroxysmal discharge of abnormal rhythms in some part of the brain” [2]. In order to differentiate between the two, simultaneous electroen-cephalographic (EEG) and electrocardiographic (ECG) recording with multiple scalp and chest electrodes is required, a situation that is rarely fulfilled.


Seizure Disorder Myoclonic Jerk Cardiac Conduction System Electrocardiographic Monitoring Epileptic Attack 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brignole M, Alboni P, Benditt D et al (2001) Task Force report. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 22:1256–1306PubMedCrossRefGoogle Scholar
  2. 2.
    Bannister R (1973) Brain’s clinical neurology. Oxford Medical, London, New York, Delhi, p 142Google Scholar
  3. 3.
    Lempert T, Bauer M, Schmidt D (1994) Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol 36:233–237PubMedCrossRefGoogle Scholar
  4. 4.
    Linzer M, Grubb BP, Ho S et al (1994) Cardiovascular causes of loss of consciousness in patients with presumed epilepsy: a cause of the increased sudden death rate in people with epilepsy? Am J Med 96:146–154PubMedCrossRefGoogle Scholar
  5. 5.
    Englund A, Bergfeldt L, Rosenqvist M (1998) Pharmacological stress-testing of the His-Purkinje system in patients with bifascicular block. Pacing Clin Electrophysiol 21:1979–1987PubMedCrossRefGoogle Scholar
  6. 6.
    Kennebäck G, Bergfeldt L, Vallin H et al (1991) Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system. Am Heart J 121:1421–1429PubMedCrossRefGoogle Scholar
  7. 7.
    Kennebäck G, Bergfeldt L, Tomson T et al (1992) Carbamazepine-induced bradycardia — a problem in general or only in susceptible patients? A 24 h long-term electrocardiogram study. Epilepsy Res 13:141–145PubMedCrossRefGoogle Scholar
  8. 8.
    Kennebäck G, Bergfeldt L, Tomson T (1995) Electrophysiological evaluation of the sodium-channel blocker carbamazepine in healthy human subjects. Cardiovasc Drugs Ther 9:709–714PubMedCrossRefGoogle Scholar
  9. 9.
    Keilson MJ, Häuser A, Magrill JP, Goldman M (1987) ECG abnormalities in patients with epilepsy. Neurology 37:1624–1626PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2002

Authors and Affiliations

  • L. Bergfeldt
    • 1
  1. 1.Department of Cardiology, Karolinska HospitalElectrophysiology and Arrhythmia ServiceStockholmSweden

Personalised recommendations